Inventor · disambiguated record
Chuan-Fa Liu
Also filed as: BOONE THOMAS CHARLES · LIU CHUAN · LIU CHUAN-FA
27 granted patents·17 pending applications·1,138 citations·filing 1999–2025
96Inventor score
Top patents by PatentIndex Score
44 records- 0198US6660843B1Modified peptides as therapeutic agentsAMGEN INC·Filed 1999·Granted Dec 9, 2003·631 cites·10 claims
- 0297US6835809B1Thrombopoietic compoundsAMGEN INC·Filed 1999·Granted Dec 28, 2004·193 cites·3 claims
- 0396US6756480B2Modulators of receptors for parathyroid hormone and parathyroid hormone-related proteinAMGEN INC·Filed 2001·Granted Jun 29, 2004·254 cites·24 claims
- 0494US7488590B2Modified peptides as therapeutic agentsAMGEN INC·Filed 2003·Granted Feb 10, 2009·33 cites·13 claims
- 0587US7994117B2Thrombopoietic compoundsAMGEN INC·Filed 2009·Granted Aug 9, 2011·5 cites·5 claims
- 0684US11338000B2Use of Butyribacter intestini in preventing and/or treating inflammation-related diseasesBGI SHENZHEN·Filed 2017·Granted May 24, 2022·2 cites·18 claims
- 0783US8618044B2Thrombopoietic compoundsLIU CHUAN-FA·Filed 2012·Granted Dec 31, 2013·4 cites·24 claims
- 0882US8748571B2Thrombopoietic compoundsLIU CHUAN-FA·Filed 2011·Granted Jun 10, 2014·4 cites·28 claims
- 0979US11160837B2Megamonas funiformis and applications thereofBGI SHENZHEN·Filed 2017·Granted Nov 2, 2021·1 cites·10 claims
- 1077US11376289B2Composition and uses thereofBGI SHENZHEN·Filed 2018·Granted Jul 5, 2022·2 cites·20 claims
- 1175US9145450B2Thrombopoietic compoundsLIU CHUAN-FA·Filed 2006·Granted Sep 29, 2015·1 cites·23 claims
- 1273US8044174B2Thrombopoietic compoundsAMGEN INC·Filed 2004·Granted Oct 25, 2011·4 cites·8 claims
- 1372US9453044B2Method of synthesizing peptides, proteins and bioconjugatesUNIV NANYANG TECH·Filed 2013·Granted Sep 27, 2016·1 cites·20 claims
- 1472US7605120B2Antagonists of the brandykinin B1 receptorAMGEN INC·Filed 2004·Granted Oct 20, 2009·2 cites·11 claims
- 1572US2009048149A1Antagonists of the bradykinin B1 receptorAMGEN INC·Filed 2008·Application pending·0 cites
- 1670US11033614B2Intestinal bacteria butyribacterintestini and application thereofBGI SHENZHEN·Filed 2016·Granted Jun 15, 2021·1 cites·3 claims
- 1769US2024263210A1Methods for enzymatic peptide ligationUNIV NANYANG TECH·Filed 2023·Application pending·0 cites
- 1867US11484583B2Intestinal bacteria Butyribacter intestini and application thereofBGI SHENZHEN·Filed 2021·Granted Nov 1, 2022·0 cites·17 claims
- 1967US9534032B2Thrombopoietic compoundsAMGEN INC·Filed 2014·Granted Jan 3, 2017·0 cites·6 claims
- 2067US2023128192A1Methods for enzymatic peptide ligationUNIV NANYANG TECH·Filed 2022·Application pending·0 cites
- 2165US8288351B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 16, 2012·0 cites·14 claims
- 2265US8278280B2Antagonists of the bradykinin B1 receptorNG GORDON·Filed 2008·Granted Oct 2, 2012·0 cites·14 claims
- 2362US2024167070A1METHODS FOR CYCLIZATION OF (POLY)PEPTIDES COMPRISING Ny-HYDROXY- OR Ny-AMINO-L-ASPARAGINEUNIV NANYANG TECH·Filed 2022·Application pending·0 cites
- 2462US2007142295A1Thrombopoietic compoundsAMGEN INC·Filed 2006·Application pending·0 cites
- 2562US2007049532A1Modified peptides as therapeutic agentsAMGEN INC·Filed 2006·Application pending·0 cites
- 2661US10806759B2Christensenella intestinihominis and application thereofBGI SHENZHEN·Filed 2016·Granted Oct 20, 2020·0 cites·19 claims
- 2758US2025270610A1Improving the Efficiency of PAL-Catalyzed Protein Ligation By A Cascade Enzymatic SchemeUNIV NANYANG TECH·Filed 2023·Application pending·0 cites
- 2857US2004071712A1Modified peptides as therapeutic agentsAMGEN INC·Filed 2003·Application pending·0 cites
- 2956US2024117402A1Methods for (poly) peptide tandem ligation and cyclizationUNIV NANYANG TECH·Filed 2022·Application pending·0 cites
- 3055US11795488B2Methods for enzymatic peptide ligationUNIV NANYANG TECH·Filed 2017·Granted Oct 24, 2023·0 cites·12 claims
- 3154US2025333409A1Compound and use thereof in preparation of BCL-XL inhibitorHITGEN INC·Filed 2023·Application pending·0 cites
- 3253US2025136593A1Degradation agent and use thereofHITGEN INC·Filed 2022·Application pending·0 cites
- 3352US2009305975A1Use of Trap Protein Per se as an Active Ingredient for the Manufacture of a Medicament for the Treatment of Staphylococcus Aureus InfectionYANG GUANG·Filed 2007·Application pending·0 cites
- 3451US11191790B2Biologically pure Faecalibacterium butyricigenerans strain, composition including the same and method for treating ulcerative colitisBGI SHENZHEN·Filed 2019·Granted Dec 7, 2021·0 cites·13 claims
- 3550US2004214996A1Modulators of receptors for parathyroid hormone and parathyroid hormone-related proteinAMGEN INC·Filed 2004·Application pending·0 cites
- 3649US2022213461A1Asx-specific protein ligases and uses thereofUNIV NANYANG TECH·Filed 2020·Application pending·0 cites
- 3747US2002090646A1Calcitonin-related moleculesAMGEN INC·Filed 2001·Application pending·0 cites
- 3846US8859490B2Peptide nucleic acid monomers and oligomersLIU CHUAN FA·Filed 2008·Granted Oct 14, 2014·0 cites·12 claims
- 3944US9023957B2Compound for use in peptide synthesisLIU CHUAN FA·Filed 2011·Granted May 5, 2015·0 cites·26 claims
- 4044US2006234307A1Modified peptides as therapeutic agentsAMGEN INC·Filed 2006·Application pending·0 cites
- 4143US10799540B2Faecalibacterium longum and application thereofBGI SHENZHEN·Filed 2016·Granted Oct 13, 2020·0 cites·20 claims
- 4241US11091786B2Butelase-mediated peptide ligationUNIV NANYANG TECH·Filed 2016·Granted Aug 17, 2021·0 cites·20 claims
- 4339US9309278B2Method for modification of organic moleculesLIU CHUAN-FA·Filed 2012·Granted Apr 12, 2016·0 cites·18 claims
- 4434US2025163070A1Spiro compound and application thereofHITGEN INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chuan-Fa Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →